on Catheter Precision, Inc
Catheter Precision to Attend International Atrial Fibrillation Symposium
Catheter Precision, Inc., a US-based medical device company listed on NYSE American as VTAK, announced its participation in the 30th International Atrial Fibrillation Symposium. This event will be held from January 16 to 18, 2025, in Boston, Massachusetts. Established in 1995, the symposium has grown into a significant scientific forum, providing healthcare professionals the chance to learn about developments in atrial fibrillation research and therapies.
According to David Jenkins, CEO of Catheter Precision, the symposium provides an opportunity for interaction with physicians in a focused environment, promoting their technologies and initiating new sales leads. The event also supports educational endeavors and peer-to-peer discussions about their products and clinical practices.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Catheter Precision, Inc news